» Journals » Br J Haematol

British Journal of Haematology

The British Journal of Haematology is a renowned peer-reviewed medical journal that focuses on all aspects of haematology, including clinical and laboratory research, diagnosis, treatment, and management of blood disorders. It publishes high-quality articles, reviews, and case reports, providing valuable insights into the latest advancements in the field.

Details
Abbr. Br J Haematol
Start 1955
End Continuing
Frequency Twenty three times a year, 2003-
p-ISSN 0007-1048
e-ISSN 1365-2141
Country United Kingdom
Language English
Specialty Hematology
Metrics
h-index / Ranks: 644 208
SJR / Ranks: 1809 1574
CiteScore / Ranks: 2299 7.90
JIF / Ranks: 979 6.5
Recent Articles
1.
Liu J, Zhao X, Chang Y, Qin Y, Jiang Q, Jiang H, et al.
Br J Haematol . 2025 Mar; PMID: 40081934
This study evaluated the kinetics of KMT2A-r during chemotherapy and its impact on allogeneic haematopoietic stem cell transplantation (allo-HSCT) outcomes. KMT2A-r was assessed post-induction (MRD1), after the first (MRD2) and...
2.
Veloza L, de Leval L
Br J Haematol . 2025 Mar; PMID: 40069949
No abstract available.
3.
4.
Yu T, Han S, Wang L, Wang H, Ni X, Wang R, et al.
Br J Haematol . 2025 Mar; PMID: 40069128
Primary immune thrombocytopenia (ITP) is a haemorrhagic disorder with a complex pathogenesis, wherein autoreactive B-cell-mediated platelet destruction plays a crucial role. Bruton's tyrosine kinase (BTK) is widely expressed and essential...
5.
Sugio T, Miyawaki K, Uchida N, Niemann M, Spierings E, Mori K, et al.
Br J Haematol . 2025 Mar; PMID: 40065633
Cord blood transplantation (CBT) is a valuable donor source for patients without human leukocyte antigen (HLA)-matched donors. While CBT has a lower risk of graft-versus-host disease and requires less stringent...
6.
Lee J, Oh S, Lee T, Lee S, Kim N, Pak M, et al.
Br J Haematol . 2025 Mar; PMID: 40065083
No abstract available.
7.
Suttorp M, Sembill S, Lensker P, Hildebrand V, Schirmer E, Karow A, et al.
Br J Haematol . 2025 Mar; PMID: 40059620
Imatinib (IMA) therapy for paediatric chronic myeloid leukemia (pCML) requires age-dependent dose adjustments. Assessment of therapeutic drug monitoring (TDM) under 'real-world' conditions was performed. Collection of blood and TDM-relevant data,...
8.
9.
Balciuniene J, Yilmaz S, Chonat S, Grace R, Soff G, Ravindranath Y, et al.
Br J Haematol . 2025 Mar; PMID: 40058880
Data from a large cohort of individuals referred for NGS testing evaluate the utility of next-generation sequencing in clinical practice for diagnosing hereditary haemolytic anaemias.
10.
Urbain F, Labeyrie C, Castilla-Llorente C, Noel N, Farge D, Echaniz-Laguna A
Br J Haematol . 2025 Mar; 206(3):996-999. PMID: 40052451
No abstract available.